Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 3
2005 2
2006 5
2007 5
2008 6
2009 3
2010 3
2011 6
2012 6
2013 2
2014 9
2015 6
2016 7
2017 9
2018 11
2019 19
2020 29
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

121 results
Results by year
Filters applied: . Clear all
Page 1
Olaparib for the treatment of breast cancer.
Griguolo G, Dieci MV, Guarneri V, Conte P. Griguolo G, et al. Among authors: guarneri v. Expert Rev Anticancer Ther. 2018 Jun;18(6):519-530. doi: 10.1080/14737140.2018.1458613. Epub 2018 Mar 30. Expert Rev Anticancer Ther. 2018. PMID: 29582690 Review.
Cancer and COVID-19: what do we really know?
Poortmans PM, Guarneri V, Cardoso MJ. Poortmans PM, et al. Among authors: guarneri v. Lancet. 2020 Jun 20;395(10241):1884-1885. doi: 10.1016/S0140-6736(20)31240-X. Epub 2020 May 29. Lancet. 2020. PMID: 32479827 Free PMC article. No abstract available.
Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2-, Node-Positive, High-Risk, Early Breast Cancer (monarchE).
Johnston SRD, Harbeck N, Hegg R, Toi M, Martin M, Shao ZM, Zhang QY, Martinez Rodriguez JL, Campone M, Hamilton E, Sohn J, Guarneri V, Okada M, Boyle F, Neven P, Cort├ęs J, Huober J, Wardley A, Tolaney SM, Cicin I, Smith IC, Frenzel M, Headley D, Wei R, San Antonio B, Hulstijn M, Cox J, O'Shaughnessy J, Rastogi P; monarchE Committee Members and Investigators. Johnston SRD, et al. Among authors: guarneri v. J Clin Oncol. 2020 Dec 1;38(34):3987-3998. doi: 10.1200/JCO.20.02514. Epub 2020 Sep 20. J Clin Oncol. 2020. PMID: 32954927
Current strategies for the targeted treatment of high-grade serous epithelial ovarian cancer and relevance of BRCA mutational status.
Gadducci A, Guarneri V, Peccatori FA, Ronzino G, Scandurra G, Zamagni C, Zola P, Salutari V. Gadducci A, et al. Among authors: guarneri v. J Ovarian Res. 2019 Jan 28;12(1):9. doi: 10.1186/s13048-019-0484-6. J Ovarian Res. 2019. PMID: 30691488 Free PMC article. Review.
Potent Cell-Cycle Inhibition and Upregulation of Immune Response with Abemaciclib and Anastrozole in neoMONARCH, Phase II Neoadjuvant Study in HR+/HER2- Breast Cancer.
Hurvitz SA, Martin M, Press MF, Chan D, Fernandez-Abad M, Petru E, Rostorfer R, Guarneri V, Huang CS, Barriga S, Wijayawardana S, Brahmachary M, Ebert PJ, Hossain A, Liu J, Abel A, Aggarwal A, Jansen VM, Slamon DJ. Hurvitz SA, et al. Among authors: guarneri v. Clin Cancer Res. 2020 Feb 1;26(3):566-580. doi: 10.1158/1078-0432.CCR-19-1425. Epub 2019 Oct 15. Clin Cancer Res. 2020. PMID: 31615937 Free PMC article. Clinical Trial.
Recommendations for the implementation of BRCA testing in ovarian cancer patients and their relatives.
Gori S, Barberis M, Bella MA, Buttitta F, Capoluongo E, Carrera P, Colombo N, Cortesi L, Genuardi M, Gion M, Guarneri V, Incorvaia L, La Verde N, Lorusso D, Marchetti A, Marchetti P, Normanno N, Pasini B, Pensabene M, Pignata S, Radice P, Ricevuto E, Sapino A, Tagliaferri P, Tassone P, Trevisiol C, Truini M, Varesco L, Russo A; AIOM-SIGU-SIBIOC-SIAPEC-IAP Working Group. Gori S, et al. Among authors: guarneri v. Crit Rev Oncol Hematol. 2019 Aug;140:67-72. doi: 10.1016/j.critrevonc.2019.05.012. Epub 2019 May 25. Crit Rev Oncol Hematol. 2019. PMID: 31176273 Free article.
Olaparib for advanced breast cancer.
Griguolo G, Dieci MV, Miglietta F, Guarneri V, Conte P. Griguolo G, et al. Among authors: guarneri v. Future Oncol. 2020 Apr;16(12):717-732. doi: 10.2217/fon-2019-0689. Epub 2020 Apr 6. Future Oncol. 2020. PMID: 32249603
Peripheral Blood Markers Identify Risk of Immune-Related Toxicity in Advanced Non-Small Cell Lung Cancer Treated with Immune-Checkpoint Inhibitors.
Pavan A, Calvetti L, Dal Maso A, Attili I, Del Bianco P, Pasello G, Guarneri V, Aprile G, Conte P, Bonanno L. Pavan A, et al. Among authors: guarneri v. Oncologist. 2019 Aug;24(8):1128-1136. doi: 10.1634/theoncologist.2018-0563. Epub 2019 Apr 23. Oncologist. 2019. PMID: 31015312 Free PMC article.
Biomarkers for HER2-positive metastatic breast cancer: Beyond hormone receptors.
Dieci MV, Miglietta F, Griguolo G, Guarneri V. Dieci MV, et al. Among authors: guarneri v. Cancer Treat Rev. 2020 Aug;88:102064. doi: 10.1016/j.ctrv.2020.102064. Epub 2020 Jun 24. Cancer Treat Rev. 2020. PMID: 32622272 Free article. Review.
Real world data in the era of Immune Checkpoint Inhibitors (ICIs): Increasing evidence and future applications in lung cancer.
Pasello G, Pavan A, Attili I, Bortolami A, Bonanno L, Menis J, Conte P, Guarneri V. Pasello G, et al. Among authors: guarneri v. Cancer Treat Rev. 2020 Jul;87:102031. doi: 10.1016/j.ctrv.2020.102031. Epub 2020 May 16. Cancer Treat Rev. 2020. PMID: 32446182 Free article. Review.
121 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback